Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe

被引：0
|
作者：
Julien Taieb
Thomas Seufferlein
Michele Reni
Daniel H. Palmer
John A. Bridgewater
Antonio Cubillo
Gerald W. Prager
Alice Vermeire
Fabienne Hédouin-Biville
Zhaoyang Teng
Teresa Macarulla
机构：
[1] Université de Paris,Department of Gastroenterology and Digestive Oncology
[2] Georges Pompidou European Hospital,Department of Internal Medicine I
[3] SIRIC CARPEM,Department of Medicine I
[4] Université Paris-Cité,Vall d´Hebron University Hospital
[5] Hôpital Européen Georges Pompidou,undefined
[6] Hepatogastroenterology and GI Oncology,undefined
[7] University Hospital Ulm,undefined
[8] University Vita E Salute,undefined
[9] IRCCS,undefined
[10] San Raffaele Scientific Institute,undefined
[11] University of Liverpool,undefined
[12] UCL Cancer Institute,undefined
[13] HM CIOCC University Hospital,undefined
[14] Medical University of Vienna,undefined
[15] Servier,undefined
[16] Servier Pharmaceuticals,undefined
[17] Vall d´Hebron Institute of Oncology (VHIO),undefined
[18] IOB Quiron,undefined
来源：
BMC Cancer | / 23卷
关键词：
Pancreatic cancer; Metastatic; Survival; Prognostic factors; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Palliative treatment of pancreatic adenocarcinoma in a real-world setting.
    Kordes, Maximilian
    Malgerud, Oscar
    Karimi, Masoud
    Frodin, Jan-Erik
    Liljefors, Maria Gustafsson
    Loehr, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma (mPAC) patients in real world across Europe
    Taieb, J.
    Carrato, A.
    AMellbring
    Prager, G.
    Melisi, D.
    Westphalen, B.
    Macarulla Mercade, T.
    D'Esquermes, N.
    Ferreras, A.
    De Jong, F.
    ANNALS OF ONCOLOGY, 2018, 29 : 100 - +
  • [23] Predictive and prognostic factors in metastatic colorectal cancer patients treated with fruquintinib: A multicenter real-world analysis
    Zhang, C.
    Wang, Y.
    Xu, J.
    Dong, M.
    Liu, K.
    Lu, Y.
    Chen, K.
    Cao, Y.
    Shi, H.
    Bei, Y.
    Li, J.
    Zhao, J.
    Cao, Y.
    Lu, N.
    Liu, H.
    Cai, P.
    Li, K.
    Yang, T.
    He, N.
    Dong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S44 - S44
  • [24] Fruquintinib in metastatic colorectal cancer: a multicenter real-world analysis on efficacy, safety, and predictive and prognostic factors
    Wang, Yi
    Xu, Jianfen
    Dong, Mingjun
    Liu, Kaitai
    Lu, Yi
    Chen, Ke
    Cao, Yuepeng
    Shi, Hang
    Bei, Yanping
    Li, Jianjiong
    Zhao, Jianpei
    Cao, Yisheng
    Lu, Ning
    Yang, Lu
    Liu, Haizhong
    Cai, Ping
    Li, Kai
    Yang, Tong
    He, Ning
    Dong, Jing
    Zhang, Chen
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04) : 1519 - 1533
  • [25] Real-world evidence on long-term survivors of metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with liposomal irinotecan: NALLONG study
    Ueno, M.
    Yoo, C.
    Macarulla Mercade, T.
    Westphalen, C. B.
    Prager, G.
    Imaoka, H.
    Waldschmidt, D. T.
    Verslype, C.
    Okusaka, T.
    Ryoo, B-Y.
    Hedouin-Biville, F.
    Chevallier, B.
    van Laethem, J-L.
    ANNALS OF ONCOLOGY, 2024, 35 : S928 - S929
  • [26] Response to "Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy"
    Narayanan, Sowmya
    Paniccia, Alessandro
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (06) : 1072 - 1072
  • [27] Real-world treatment patterns and total cost of care in Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX
    Hirsch, Jared
    Cockrum, Paul
    Tomicki, Samantha
    Dieguez, Gabriela
    Bhatt, Prachi
    Kim, George P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] REAL-WORLD 30-DAY READMISSION PATTERNS AMONG COMMERCIALLY INSURED PATIENTS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
    Kim, G. P.
    Surinach, A.
    Cockrum, P.
    VALUE IN HEALTH, 2022, 25 (07) : S310 - S311
  • [29] NALIRIFOX Versus FOLFOX as First-oLine Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC): Real-World Comparative Overall (OS) Survival Analysis
    O'Reilly, Eileen
    Li, Jia
    DerSarkissian, Maral
    Chang, Rose
    Cheng, Mu
    Yu, Louise
    Rane, Deepali
    Zhang, Li
    Xiao, Zhimin
    Benzaghou, Fawzi
    Duh, Mei Sheng
    Chen, Huanyu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 176 - 176
  • [30] Radium-223 treatment in Metastatic Prostate Cancer: Prognostic Factors: Real-world Outcome
    Pearson, R.
    Jiang, X.
    Atkinson, S.
    Cumming, S.
    Burns, A.
    Frew, J.
    McMenemin, R.
    Pedley, I.
    Azzabi, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S855 - S855
12345